Jazz Pharmaceuticals plc - FORM 10-K/A - EX-31.4 - CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - April 27, 2012

Attached files

file filename
10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Jazz Pharmaceuticals plcd340364d10ka.htm
EX-31.3 - CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) - Jazz Pharmaceuticals plcd340364dex313.htm
EX-10.34 - AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AND SEVERANCE BENEFIT PLAN - Jazz Pharmaceuticals plcd340364dex1034.htm
EX-10.33 - JAZZ PHARMACEUTICALS PLC CASH BONUS PLAN - Jazz Pharmaceuticals plcd340364dex1033.htm

EXHIBIT 31.4

CERTIFICATION

I, Kathryn E. Falberg, certify that:

 

  1. I have reviewed this Amendment No. 1 to the annual report on Form 10-K/A of Jazz Pharmaceuticals Public Limited Company (filed on behalf of and as successor to Jazz Pharmaceuticals, Inc.); and

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Date: April 27, 2012

   By:  

/s/    KATHRYN E. FALBERG

    Kathryn E. Falberg
    Executive Vice President and Chief Financial Officer

 

Stock widget

Investing forum

Jazz Pharmaceuticals plc Reports